Thailand’s billion-dollar bid to become a pharmaceutical powerhouse is hitting turbulence – swelling patent backlogs, looming price caps and tougher regulations are unnerving investors and jeopardizing the industry’s long-term prospects
Across Asia, insurers are placing big bets on costly, cutting-edge treatments – from gene therapies to next-generation biologics – hoping they’ll pay off by preventing chronic complications and slashing long-term healthcare costs and expensive hospital readmissions
A new Bioengineer.org study reveals that aging populations across South Asia are driving a rapid surge in government health spending – squeezing budgets and forcing policymakers to rethink priorities
Bain’s “Asia-Pacific Front Line of Healthcare 2026” report reveals a region in rapid transformation: digital tools are being adopted at lightning speed, private investment is pouring in, and rising patient expectations are reshaping how care is delivered across the Asia-Pacific
A new FSI study warns that Asia’s fast‑aging societies are driving a sharp rise in chronic illness and care costs – even as life expectancy climbs and individual health measures continue to improve
The Saw Swee Hock School’s MScHEOR trains the next generation of health-economics leaders with rigorous, practical skills to champion evidence-based care and empower bold policy innovation across Asia’s fast-evolving health systems